Ephraim Philip Lansky

Summary

Publications

  1. ncbi Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions
    Ephraim P Lansky
    Rimonest Ltd, Horev Center, Box 9945, Haifa, Israel
    Invest New Drugs 23:11-20. 2005
  2. ncbi Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo
    Masakazu Toi
    Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Angiogenesis 6:121-8. 2003
  3. ncbi Beware of pomegranates bearing 40% ellagic Acid
    Ephraim Philip Lansky
    Rimonest Ltd, Haifa, Israel
    J Med Food 9:119-22. 2006
  4. ncbi Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel
    Ephraim Philip Lansky
    Rimonest Ltd, P.O.B. 9945, Haifa, Israel
    Invest New Drugs 23:121-2. 2005
  5. ncbi Punica granatum: heuristic treatment for diabetes mellitus
    Sarah Rachel Katz
    Rimonest Ltd, Haifa, Israel
    J Med Food 10:213-7. 2007
  6. ncbi Ficus spp. (fig): ethnobotany and potential as anticancer and anti-inflammatory agents
    Ephraim Philip Lansky
    Punisyn Pharmaceuticals, POB 9945, Haifa, Israel
    J Ethnopharmacol 119:195-213. 2008
  7. ncbi A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants
    Shay Y Schubert
    The Interdepartmental Program in Biotechnology, Bruce Rappaport Research Institute and the Rappaport Faculty of Medicine, Technion, Haifa, Israel
    FASEB J 16:1931-3. 2002

Collaborators

Detail Information

Publications7

  1. ncbi Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions
    Ephraim P Lansky
    Rimonest Ltd, Horev Center, Box 9945, Haifa, Israel
    Invest New Drugs 23:11-20. 2005
    ..The results suggest vertical as well as the usual horizontal strategies for discovering pharmacological actives in plants...
  2. ncbi Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo
    Masakazu Toi
    Department of Surgery, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
    Angiogenesis 6:121-8. 2003
    ....
  3. ncbi Beware of pomegranates bearing 40% ellagic Acid
    Ephraim Philip Lansky
    Rimonest Ltd, Haifa, Israel
    J Med Food 9:119-22. 2006
    ..The implications of this strategy may be generalized for the optimization of nutraceutical preparations from other medicinal plants as well...
  4. ncbi Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel
    Ephraim Philip Lansky
    Rimonest Ltd, P.O.B. 9945, Haifa, Israel
    Invest New Drugs 23:121-2. 2005
    ..When C, P, and L were equally combined at the same gross dosage (4 microg/ml) as when the compounds were tested individually, a supradditive inhibition of invasion was observed, measured by the Kruskal-Wallis non-parametric test...
  5. ncbi Punica granatum: heuristic treatment for diabetes mellitus
    Sarah Rachel Katz
    Rimonest Ltd, Haifa, Israel
    J Med Food 10:213-7. 2007
    ..Pomegranate fractions and their active compounds hold potential and are worthy of further investigations as safe and effective medical treatments for diabetes mellitus and its pathological consequences...
  6. ncbi Ficus spp. (fig): ethnobotany and potential as anticancer and anti-inflammatory agents
    Ephraim Philip Lansky
    Punisyn Pharmaceuticals, POB 9945, Haifa, Israel
    J Ethnopharmacol 119:195-213. 2008
    ....
  7. ncbi A novel mechanism for the inhibition of NF-kappaB activation in vascular endothelial cells by natural antioxidants
    Shay Y Schubert
    The Interdepartmental Program in Biotechnology, Bruce Rappaport Research Institute and the Rappaport Faculty of Medicine, Technion, Haifa, Israel
    FASEB J 16:1931-3. 2002
    ..Thus, natural antioxidants may serve as potent NF-kappaB inhibitors in vascular endothelial cells, yet act through unique and divergent pathways...